三级aa视频在线观看-三级国产-三级国产精品一区二区-三级国产三级在线-三级国产在线

US EUROPE AFRICA ASIA 中文
Business / Companies

Biotech boom, pride of Anhui

By Zhu Lixin (China Daily) Updated: 2016-07-19 08:14

Biotech boom, pride of Anhui

A bird's-eye view of the world's largest biotech drug production base in Hefei, Anhui province. The facility is shaped in the form of antibody ATCG. [Photo provided to China Daily]

Beijing-based Sinobioway Group Co Ltd, a major biotech company in China, is building the world's largest biotech drug production base at the Bantang township in Hefei, capital of Anhui province in East China.

The facility, shaped in the form of antibody ATCG and to be called the Bantang Bioeconomy Experimental Zone, will have 100 production lines to be completed in 10 to 15 years. The first five lines will be completed by the end of this year.

Work on another 10 will also start later this year, said Cao Wenbo, president of Anhui Sinobioway Bioeconomy Group, a subsidiary of Sinobioway Group.

The zone covers an area of 31 sq km. A 400,000-sq-meter plant is almost ready; the next two phases will take up 600,000 sq m.

Cao said infrastructure excluding the production lines will see an investment of 1.5 billion yuan ($224.3 million), which is being provided by the Hefei government.

Wu Cunrong, Party chief of Hefei city, said: "We believe the biotech drug sector will see enormous growth opportunities in future, so we will surely support such companies."

The company, Cao said, will repay the money in five years "so that we can have more money for mergers and acquisitions. We have enough money to reach the goal."

There are dozens of funds to back the ambitious project, which is expected to cost billions of yuan, he said.

"Instead of starting from the R&D stage, Sinobioway is more interested in buying drug patents and firms at home and abroad. Biotech drug production has been very profitable. But starting everything from R&D will be too time-consuming and risky. You may spend years but get nothing."

He said buying patents and firms will bring the company high profits quickly. During the process, it will also develop its own drugs.

This business model has marked the collaboration between Sinobioway and BioAlta, a San Diego-based company focused on the development of Conditionally Active Biologic antibody therapeutics.

In 2015, the two companies forged a strategic collaboration for the development and commercialization of select CAB antibodies and other CAB-based therapeutics in China. "Production of all the drugs will be based in Hefei," said Cao.

BioAlta would receive more than $70 million in payments and investment from Sinobioway in a year, according to their agreement.

Hot Topics

Editor's Picks
...
主站蜘蛛池模板: 久久国内| 加勒比色老久久爱综合网 | 色偷偷亚洲第一成人综合网址 | 久久精品欧美一区二区 | 久久综合偷拍 | 国产婷婷一区二区在线观看 | 亚洲午夜精品国产电影在线观看 | 男女做a一级视频免费观看 男女喷水视频 | 玖玖精品视频在线观看 | 黄色片国产| 在线免费国产视频 | 日日夜夜操操操 | 亚洲精品日韩中文字幕久久久 | 精品国产欧美sv在线观看 | 黄色a级免费网站 | 黄色视频一级毛片 | 1769国产精品视频免费观看 | 欧美成人免费观看 | 久久婷婷久久一区二区三区 | 在线亚洲欧洲福利视频 | 国产毛片在线视频 | 中文字幕片| 美女草| 亚州黄色网址 | 俄罗斯美女bbbbxx | 国产三级黄色片 | 免费看成人国产一区二区三区 | 久久国产偷 | 国产精品免费视频播放 | 婷婷久久综合九色综合九七 | 久久久夜色精品国产噜噜 | 国产区网址 | 免费影院在线 | 91无套极品外围在线播放 | 在线观看欧美大片 | 国产精品国产高清国产专区 | 黄色视片 | 久久亚洲国产 | 69交性视频| 欧美一级大尺度毛片 | 久久精品国产这里是免费 |